Cargando…
Lymphadenopathy in the era of COVID-19 vaccination – an oncological dilemma in diagnostic imaging
Initial clinical experience with COVID-19 vaccination suggests that approved COVID-19 mRNA vaccines induce a strong immune response and thus cause a significantly higher incidence of axillary lymphadenopathy compared with other vaccines. It can therefore be expected to complicate the diagnosis of pa...
Autores principales: | Samkowski, Jakub, Sklinda, Katarzyna, Walecki, Jerzy Michał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288197/ https://www.ncbi.nlm.nih.gov/pubmed/35892070 http://dx.doi.org/10.5114/pjr.2022.117560 |
Ejemplares similares
-
Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncology Patients
por: Özütemiz, Can, et al.
Publicado: (2021) -
Neuroimaging of Cerebral Venous Thrombosis (CVT) – Old Dilemma and the New Diagnostic Methods
por: Walecki, Jerzy, et al.
Publicado: (2015) -
MEDIASTINAL LYMPHADENOPATHY AFTER COVID-19 VACCINE: STAGING DILEMMA IN ONCOLOGY PATIENTS
por: TRIKANNAD, ANUP, et al.
Publicado: (2021) -
COVID-19 severity scoring systems in radiological imaging – a review
por: Wasilewski, Piotr G., et al.
Publicado: (2020) -
Active Surveillance of Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: A Review of the Current Role and Future Perspectives
por: Sklinda, Katarzyna, et al.
Publicado: (2020)